RedHill Biopharma (RDHL) Current Assets: 2012-2025
Historic Current Assets for RedHill Biopharma (RDHL) over the last 1 years, with Jun 2025 value amounting to $12.6 million.
- RedHill Biopharma's Current Assets fell 20.05% to $12.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $12.6 million, marking a year-over-year decrease of 20.05%. This contributed to the annual value of $11.9 million for FY2024, which is 26.20% down from last year.
- RedHill Biopharma's Current Assets amounted to $12.6 million in Q2 2025, which was up 5.41% from $11.9 million recorded in Q4 2024.
- RedHill Biopharma's Current Assets' 5-year high stood at $98.5 million during Q2 2021, with a 5-year trough of $11.9 million in Q4 2024.
- In the last 3 years, RedHill Biopharma's Current Assets had a median value of $15.7 million in 2024 and averaged $16.7 million.
- Per our database at Business Quant, RedHill Biopharma's Current Assets skyrocketed by 61.13% in 2021 and then plummeted by 81.21% in 2023.
- RedHill Biopharma's Current Assets (Quarterly) stood at $89.2 million in 2021, then dropped by 3.65% to $85.9 million in 2022, then slumped by 81.21% to $16.1 million in 2023, then decreased by 26.20% to $11.9 million in 2024, then fell by 20.05% to $12.6 million in 2025.
- Its Current Assets was $12.6 million in Q2 2025, compared to $11.9 million in Q4 2024 and $15.7 million in Q2 2024.